J.P. Morgan lowered forecasts for the U.S. and global knee and hip market, which means the third quarter forecasts for these companies is also low. The price target for Stryker decreased from $58 to $49, Zimmer from $63 to $58 and Wright from $21 to $17.
Read the Benzinga report on J.P. Morgan’s lowered forecasts.
Read other coverage on orthopedic device companies:
– VertiFlex Sells Silverbolt Product Portfolio to Exatech
– Stryker Acquires Gaymar Industries
– Medtronic Lowers Profit Forecast, Incurs Price Drop
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
